# To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects

> **NCT06473948** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Jemincare** · enrollment: 27 (estimated)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **DRUG:** JMKX001899
- **DRUG:** JMKX001899
- **DRUG:** JMKX001899
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06473948
- **Lead sponsor:** Jemincare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-10
- **Primary completion:** 2024-09-24
- **Final completion:** 2025-02-27
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2024-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06473948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06473948, "To Assess the Effects of Single Dose of JMKX001899 on QTc Interval in Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06473948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*